Research Comparison

IGF-1 vs Ipamorelin

Side-by-side research comparison of IGF-1 and Ipamorelin across our PubMed, ClinicalTrials.gov, and EuropePMC corpus. 3 head-to-head studies plus 109 on IGF-1 and 45 on Ipamorelin.

3 head-to-head · 109 on IGF-1 · 45 on Ipamorelin

At a glance

  IGF-1 Ipamorelin
Drug class growth factor ghrh secretagogue, ghrelin mimetic
Studies in corpus 109 45
Highest evidence tier meta analysis rct
Evidence tier mix cohort · 5 rct · 22 other · 27 case series · 1 meta analysis · 2 case report · 2 review · 12 preclinical animal · 27 in vitro · 6 other · 12 preclinical animal · 22 rct · 4 in vitro · 5 review · 1
Studies with explicit sample size 10 3
Head-to-head studies in corpus 3

Lab evidence, head to head

Beyond the literature: here's what third-party Certificate-of-Analysis records (Janoshik, BCC, Auxlabs) say about real IGF-1 and Ipamorelin batches we've tested. Aggregate, public data — cross-reference against the studies below.

IGF-1

We tested 17 IGF-1 batches across 10 manufacturers, 99.17% avg purity.

17
Batches tested
10
Manufacturers
99.17%
Avg purity
All IGF-1 COA records →

Ipamorelin

We tested 1805 Ipamorelin batches across 638 manufacturers, 99.52% avg purity.

1805
Batches tested
638
Manufacturers
99.52%
Avg purity
10
Failed <90%
143
Underdosed >10%
All Ipamorelin COA records →

We hold deeper lab coverage on Ipamorelin (1805 batches tested). Ipamorelin edges ahead on average measured purity (99.17% vs 99.52%) — a narrow gap; weigh it against failed-batch and underdose counts above.

Head-to-head studies

Studies in our corpus that mention both IGF-1 and Ipamorelin — the gold-standard direct comparison evidence.

Top studies per peptide

Vendor data

Looking for vendor-level purity, endotoxin, and HPLC data on IGF-1 or Ipamorelin? TitrateLab tracks Certificate-of-Analysis records from the major peptide labs (Janoshik, BCC, Auxlabs) alongside the research above. Cross-reference vendor batches against the studies on this page.

Explore each peptide